Literature DB >> 31993777

Progestogen Sensitization: a Unique Female Presentation of Anaphylaxis.

Jonathan A Bernstein1.   

Abstract

PURPOSE OF REVIEW: Progestogen hypersensitivity (PH) is a condition which typically occurs in women in childbearing years with a spectrum of symptoms ranging from urticaria with or without angioedema, dermatitis to systemic anaphylaxis. Herein, a clinical case of PH is presented followed by a discussion on the evaluation, diagnosis, and management of PH. RECENT
FINDINGS: Progestogen hypersensitivity (a.k.a. "autoimmune progesterone dermatitis") symptoms are associated with exogenous progestin exposure (e.g., contraceptive medicines, in vitro fertilization therapy) or endogenous progesterone from progesterone surges during the luteal phase of the menstrual cycle and pregnancy. This condition can be difficult to recognize due to its heterogeneous clinical presentation. The mechanism of PH is believed to be primarily IgE-mediated; however, less commonly other immune responses may be involved. There is now a useful progesterone specific IgE immunoassay to assist in diagnosis and well-defined treatment algorithms that can be used to successfully manage PH. The epidemiology of PH is still poorly elucidated but is likely to be encountered by clinicians and especially allergists given the extensive use of oral contraceptives and increased use of supra-physiologic doses of progesterone required to support pregnancy in IVF. Including PH in the differential diagnosis of women presenting with cyclic hypersensitivity will accelerate diagnosis and successful management of this condition.

Entities:  

Keywords:  Autoimmune progesterone dermatitis; Case presentation; Clinical characteristics; Desensitization; Diagnosis and treatment; Progestogen hypersensitivity

Mesh:

Substances:

Year:  2020        PMID: 31993777     DOI: 10.1007/s11882-020-0900-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  44 in total

1.  AUTOIMMUNE PROGESTERONE DERMATITIS. CURE BY OOPHORECTOMY.

Authors:  W B SHELLEY; R W PREUCEL; S S SPOONT
Journal:  JAMA       Date:  1964-10-05       Impact factor: 56.272

2.  Hypersensitivity to gonadal hormones.

Authors:  L MELTZER
Journal:  South Med J       Date:  1963-05       Impact factor: 0.954

3.  Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile.

Authors:  Sandra M Blois; Ricarda Joachim; Judith Kandil; Ricardo Margni; Mareike Tometten; Burghard F Klapp; Petra C Arck
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

4.  Chronic idiopathic urticaria exacerbated with progesterone therapy treated with novel desensitization protocol.

Authors:  Jill A Poole; Lanny J Rosenwasser
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

5.  Autoimmune progesterone dermatitis associated with infertility treatment.

Authors:  Jennifer Jenkins; Amy Geng; Leslie Robinson-Bostom
Journal:  J Am Acad Dermatol       Date:  2008-02       Impact factor: 11.527

6.  Autoimmune progesterone dermatitis that changed its clinical manifestation from anaphylaxis to fixed drug eruption-like erythema.

Authors:  Tetsuya Honda; Kenji Kabashima; Yumiko Fujii; Mayumi Katoh; Yoshiki Miyachi
Journal:  J Dermatol       Date:  2014-04-19       Impact factor: 4.005

7.  Autoimmune progesterone urticaria.

Authors:  F S Farah; Z Shbaklu
Journal:  J Allergy Clin Immunol       Date:  1971-11       Impact factor: 10.793

8.  Progesterone sensitivity as a cause of recurrent anaphylaxis.

Authors:  W J Meggs; O H Pescovitz; D Metcalfe; D L Loriaux; G Cutler; M Kaliner
Journal:  N Engl J Med       Date:  1984-11-08       Impact factor: 91.245

Review 9.  Autoimmune progesterone dermatitis.

Authors:  A J Herzberg; C R Strohmeyer; V A Cirillo-Hyland
Journal:  J Am Acad Dermatol       Date:  1995-02       Impact factor: 11.527

10.  Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist--a preliminary report.

Authors:  J E Slater; G Raphael; G B Cutler; D L Loriaux; W J Meggs; M Kaliner
Journal:  Obstet Gynecol       Date:  1987-10       Impact factor: 7.661

View more
  1 in total

Review 1.  Perimenstrual Asthma in Adolescents: A Shared Condition in Pediatric and Gynecological Endocrinology.

Authors:  Valeria Calcaterra; Rossella Elena Nappi; Andrea Farolfi; Lara Tiranini; Virginia Rossi; Corrado Regalbuto; Gianvincenzo Zuccotti
Journal:  Children (Basel)       Date:  2022-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.